PL2952190T3 - Trwały roztwór wodny - Google Patents

Trwały roztwór wodny

Info

Publication number
PL2952190T3
PL2952190T3 PL14745605T PL14745605T PL2952190T3 PL 2952190 T3 PL2952190 T3 PL 2952190T3 PL 14745605 T PL14745605 T PL 14745605T PL 14745605 T PL14745605 T PL 14745605T PL 2952190 T3 PL2952190 T3 PL 2952190T3
Authority
PL
Poland
Prior art keywords
aqueous solution
stable aqueous
stable
solution
aqueous
Prior art date
Application number
PL14745605T
Other languages
English (en)
Inventor
Yuko Shikamura
Yuka Higashimura
Original Assignee
Senju Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co., Ltd. filed Critical Senju Pharmaceutical Co., Ltd.
Publication of PL2952190T3 publication Critical patent/PL2952190T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL14745605T 2013-01-31 2014-01-30 Trwały roztwór wodny PL2952190T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2013017877 2013-01-31
JP2013171433 2013-08-21
PCT/JP2014/052040 WO2014119642A1 (ja) 2013-01-31 2014-01-30 安定な水性液剤
EP14745605.7A EP2952190B1 (en) 2013-01-31 2014-01-30 Stable aqueous solution

Publications (1)

Publication Number Publication Date
PL2952190T3 true PL2952190T3 (pl) 2018-02-28

Family

ID=51262353

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14745605T PL2952190T3 (pl) 2013-01-31 2014-01-30 Trwały roztwór wodny

Country Status (12)

Country Link
US (1) US20150366966A1 (pl)
EP (1) EP2952190B1 (pl)
JP (1) JP5753957B2 (pl)
KR (1) KR20150110775A (pl)
CN (2) CN105007918B (pl)
BR (1) BR112015017708A2 (pl)
CA (1) CA2899292A1 (pl)
ES (1) ES2650748T3 (pl)
MX (1) MX365408B (pl)
PL (1) PL2952190T3 (pl)
RU (1) RU2665639C2 (pl)
WO (1) WO2014119642A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368621B (es) 2013-01-31 2019-10-08 Senju Pharma Co Solucion acuosa clara.
WO2018209051A1 (en) 2017-05-11 2018-11-15 Nevakar Inc. Atropine pharmaceutical compositions
CN117571642A (zh) * 2024-01-12 2024-02-20 天津世纪康泰生物医学工程有限公司 一种泰洛沙泊分光光度检测方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
JP4171529B2 (ja) 1995-06-26 2008-10-22 大正製薬株式会社 点眼剤の充填容器
JPH11228404A (ja) * 1997-12-11 1999-08-24 Senju Pharmaceut Co Ltd 安定な水性点眼剤
JP3695657B2 (ja) * 2001-02-26 2005-09-14 興和株式会社 点眼剤
PT1445258E (pt) 2001-10-12 2009-07-02 Nippon Chemiphar Co Activador para o receptor delta activado por proliferador de peroxissoma
AU2003248070A1 (en) 2002-07-16 2004-02-02 Hanshin Yoki Co., Ltd. Chemical container and method of manufacturing the container
EP1586316B1 (en) * 2003-01-21 2008-04-30 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
JP2005247800A (ja) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd 点眼剤
JP5247686B2 (ja) 2007-05-21 2013-07-24 千寿製薬株式会社 PPARδアゴニスト含有医薬
AU2008310956B2 (en) * 2007-10-08 2014-08-07 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
MX368621B (es) * 2013-01-31 2019-10-08 Senju Pharma Co Solucion acuosa clara.
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости

Also Published As

Publication number Publication date
CN105007918B (zh) 2018-06-15
EP2952190A4 (en) 2016-08-24
RU2015136804A (ru) 2017-03-06
EP2952190A1 (en) 2015-12-09
MX2015009894A (es) 2015-09-24
US20150366966A1 (en) 2015-12-24
CN105007918A (zh) 2015-10-28
RU2665639C2 (ru) 2018-09-03
CA2899292A1 (en) 2014-08-07
BR112015017708A2 (pt) 2017-07-11
MX365408B (es) 2019-05-31
JP5753957B2 (ja) 2015-07-22
CN108606951A (zh) 2018-10-02
WO2014119642A1 (ja) 2014-08-07
ES2650748T3 (es) 2018-01-22
EP2952190B1 (en) 2017-09-06
KR20150110775A (ko) 2015-10-02
JPWO2014119642A1 (ja) 2017-01-26

Similar Documents

Publication Publication Date Title
IL240863B (en) Amatoxin derivatives
SG11201506100XA (en) Pyridazinone-amides derivatives
SG11201601493UA (en) Atomizer
IL245920B (en) Ionic aqueous preparations
SI3077047T1 (sl) Soli aramchola
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
EP2974734A4 (en) LIQUID, AQUEOUS COMPOSITION
SG10201801458VA (en) Ophthalmic solution
GB201321922D0 (en) Constructions
SG11201605189YA (en) Imidazopyrazinone derivatives
PL2952190T3 (pl) Trwały roztwór wodny
EP2952189A4 (en) CLEAN AQUEOUS SOLUTION
GB201311130D0 (en) Greensleeves I
AU5187P (en) WES06 Westringia fruticosa
IL245452A0 (en) Salts of Armachol
GB201312171D0 (en) Total patent solution
GB201309252D0 (en) Total patent solution
ZA201406179B (en) Cleansing solution
GB201304401D0 (en) Simplistic Esycone
GB201308346D0 (en) Double ended match
GB201304478D0 (en) Swings